Shivaani Kummar, MD, FACP

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Fixed-Duration Acalabrutinib Plus Venetoclax Beats Chemoimmunotherapy in First-Line CLL; Adding Obinutuzumab Boosts PFS